Skip to main content

Advertisement

Log in

Posterior Reversible Encephalopathy in Sepsis-Associated Encephalopathy: Experience from a Single Center

  • Original work
  • Published:
Neurocritical Care Aims and scope Submit manuscript

An Invited Commentary to this article was published on 08 February 2022

Abstract

Background

Sepsis-associated encephalopathy (SAE) is frequently encountered in sepsis and is often accompanied by neuroimaging findings indicating ischemia, hemorrhage, and edema. Posterior reversible encephalopathy syndrome (PRES) has been vastly underrecognized in previously reported cohorts of patients with sepsis and SAE. Our aim was to determine the prevalence and distinguishing clinical, neuroimaging, and electroencephalography features of PRES in SAE.

Methods

In this prospective observational study, patients with radiologically identified PRES were selected from a consecutively enrolled cohort of 156 patients with SAE and assessed for neurological outcome using the extended Glasgow Outcome Scale for 12 months. Patients with SAE and PRES and other types of brain lesions were compared in terms of clinical and diagnostic workup features.

Results

Fourteen of 156 patients (8.9%) were determined to be radiologically compatible with PRES, whereas 48 patients displayed other types of acute brain lesions. Patients with PRES often showed lesions in atypical regions, including frontal lobes, the corpus callosum, and the basal ganglia. Source of infection was mostly gram-negative bacteria originating from pneumonia or intraabdominal infections. Patients with PRES were not different from other patients with SAE with brain lesions in terms of features of sepsis and neurological outcome. However, patients with PRES showed increased prevalence of seizures and intraabdominal source of infection.

Conclusions

PRES is highly prevalent in SAE, often encompasses unusual brain regions, and usually presents with generalized seizures. Patients with SAE and PRES do not appear to have distinguishing clinical and diagnostic workup features. However, generalized seizures may serve as warning signs for presence of PRES in patients with SAE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334(8):494–500.

    Article  CAS  PubMed  Google Scholar 

  2. Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008;29(6):1043–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14(9):914–25.

    Article  PubMed  Google Scholar 

  4. Granata G, Greco A, Iannella G, et al. Posterior reversible encephalopathy syndrome–Insight into pathogenesis, clinical variants and treatment approaches. Autoimmun Rev. 2015;14(9):830–6.

    Article  CAS  PubMed  Google Scholar 

  5. Chen Z, Shen GQ, Lerner A, Gao B. Immune system activation in the pathogenesis of posterior reversible encephalopathy syndrome. Brain Res Bull. 2017;131:93–9.

    Article  CAS  PubMed  Google Scholar 

  6. Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol. 2006;27(10):2179–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc. 2010;85(5):427–32.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Sharma A, Whitesell RT, Moran KJ. Imaging pattern of intracranial hemorrhage in the setting of posterior reversible encephalopathy syndrome. Neuroradiology. 2010;52(10):855–63.

    Article  PubMed  Google Scholar 

  9. Hefzy HM, Bartynski WS, Boardman JF, Lacomis D. Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. AJNR Am J Neuroradiol. 2009;30(7):1371–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Siebert E, Bohner G, Liebig T, Endres M, Liman TG. Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin PRES study. J Neurol. 2017;264(2):237–42.

    Article  PubMed  Google Scholar 

  11. Schweitzer AD, Parikh NS, Askin G, et al. Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome. Neuroradiology. 2017;59(4):379–86.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Gofton TE, Young GB. Sepsis-associated encephalopathy. Nat Rev Neurol. 2012;8(10):557–66.

    Article  CAS  PubMed  Google Scholar 

  13. Sonneville R, Verdonk F, Rauturier C, et al. Understanding brain dysfunction in sepsis. Ann Intensive Care. 2013;3(1):15.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Heming N, Mazeraud A, Verdonk F, Bozza FA, Chrétien F, Sharshar T. Neuroanatomy of sepsis-associated encephalopathy. Crit Care. 2017;21(1):65.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Orhun G, Tüzün E, Özcan PE, et al. Association between inflammatory markers and cognitive outcome in patients with acute brain dysfunction due to sepsis. Noro Psikiyatr Ars. 2019;56(1):63–70.

    PubMed  Google Scholar 

  16. Orhun G, Esen F, Özcan PE, et al. Neuroimaging findings in sepsis-induced brain dysfunction: association with clinical and laboratory findings. Neurocrit Care. 2019;30(1):106–17.

    Article  CAS  PubMed  Google Scholar 

  17. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165–228.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29.

    Article  CAS  PubMed  Google Scholar 

  20. Vincent JL, de Mendonça A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26(11):1793–800.

  21. Moreno R, Vincent JL, Matos R, et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med. 1999;25(7):686–96.

  22. Young GB. Coma Ann N Y Acad Sci. 2009;1157:32–47.

    Article  PubMed  Google Scholar 

  23. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286(21):2703–10.

    Article  CAS  PubMed  Google Scholar 

  24. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338–44.

    Article  PubMed  Google Scholar 

  25. Posner JB, Saper CB, Schiff ND, Plum F. Examination of the comatose patient. In: Posner JB, Saper CB, Schiff ND, Plum F, editors. Plum and Posner’s diagnosis of stupor and coma. 4th ed. Oxford: Oxford University Press; 2007. p. 38–87.

    Google Scholar 

  26. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1(7905):480–4.

    Article  CAS  PubMed  Google Scholar 

  27. Hirsch LJ, LaRoche SM, Gaspard N, et al. American clinical neurophysiology society’s standardized critical Care EEG terminology: 2012 version. J Clin Neurophysiol. 2013;30(1):1–27.

    Article  CAS  PubMed  Google Scholar 

  28. Leitinger M, Beniczky S, Rohracher A, et al. salzburg consensus criteria for non-convulsive status Epilepticus–approach to clinical application. Epilepsy Behav. 2015;49:158–63.

    Article  CAS  PubMed  Google Scholar 

  29. Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007;28(7):1320–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Liman TG, Bohner G, Heuschmann PU, Endres M, Siebert E. The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: the retrospective Berlin PRES study. J Neurol. 2012;259(1):155–64.

    Article  CAS  PubMed  Google Scholar 

  31. Suchyta MR, Jephson A, Hopkins RO. Neurologic changes during critical illness: brain imaging findings and neurobehavioral outcomes. Brain Imaging Behav. 2010;4(1):22–34.

    Article  PubMed  Google Scholar 

  32. Polito A, Eischwald F, Maho AL, et al. Pattern of brain injury in the acute setting of human septic shock. Crit Care. 2013;17(5):R204.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Sutter R, Chalela JA, Leigh R, et al. Significance of parenchymal brain damage in patients with critical illness. Neurocrit Care. 2015;23(2):243–52.

    Article  PubMed  Google Scholar 

  34. Ehler J, Petzold A, Wittstock M, et al. The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy—a prospective, pilot observational study. PLoS One. 2019;14(1):e0211184.

  35. Marra A, Vargas M, Striano P, Del Guercio L, Buonanno P, Servillo G. Posterior reversible encephalopathy syndrome: the endothelial hypotheses. Med Hypothes. 2014;82(5):619–22.

    Article  CAS  Google Scholar 

  36. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008;65(2):205–10.

    Article  PubMed  Google Scholar 

  37. Mueller-Mang C, Mang T, Pirker A, Klein K, Prchla C, Prayer D. Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance? Neuroradiology. 2009;51(6):373–83.

    Article  PubMed  Google Scholar 

  38. Feng Q, Ai YH, Gong H, et al. Characterization of sepsis and sepsis-associated encephalopathy. J Intensive Care Med. 2019;34(11–12):938–45.

    Article  PubMed  Google Scholar 

  39. Azabou E, Magalhaes E, Braconnier A, et al. Early standard electroencephalogram abnormalities predict mortality in septic intensive care unit patients. PLoS One. 2015;10(10):e0139969.

  40. Chen J, Shi X, Diao M, et al. A retrospective study of sepsis-associated encephalopathy: epidemiology, clinical features and adverse outcomes. BMC Emerg Med. 2020;20(1):77.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Cavaillon JM. Exotoxins and endotoxins: inducers of inflammatory cytokines. Toxicon. 2018;149:45–53.

    Article  CAS  PubMed  Google Scholar 

  42. Dickson K, Lehmann C. Inflammatory response to different toxins in experimental sepsis models. Int J Mol Sci. 2019;20(18):4341.

    Article  CAS  PubMed Central  Google Scholar 

  43. Hahn WO, Mikacenic C, Price BL, et al. Host derived biomarkers of inflammation, apoptosis, and endothelial activation are associated with clinical outcomes in patients with bacteremia and sepsis regardless of microbial etiology. Virulence. 2016;7(4):387–94.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Legrand M, Klijn E, Payen D, Ince C. The response of the host microcirculation to bacterial sepsis: does the pathogen matter? J Mol Med (Berl). 2010;88(2):127–33.

    Article  Google Scholar 

  45. Surbatovic M, Popovic N, Vojvodic D, et al. Cytokine profile in severe Gram-positive and Gram-negative abdominal sepsis. Sci Rep. 2015;5:11355.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Gao B, Lyu C, Lerner A, McKinney AM. Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years? J Neurol Neurosurg Psychiatry. 2018;89(1):14–20.

    Article  PubMed  Google Scholar 

  47. McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol. 2007;189(4):904–12.

    Article  PubMed  Google Scholar 

  48. Kastrup O, Schlamann M, Moenninghoff C, Forsting M, Goericke S. Posterior reversible encephalopathy syndrome: the spectrum of MR imaging patterns. Clin Neuroradiol. 2015;25(2):161–71.

    Article  CAS  PubMed  Google Scholar 

  49. Li K, Yang Y, Guo D, Sun D, Li C. Clinical and MRI features of posterior reversible encephalopathy syndrome with atypical regions: a descriptive study with a large sample size. Front Neurol. 2020;11:194.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Moon SN, Jeon SJ, Choi SS, et al. Can clinical and MRI findings predict the prognosis of variant and classical type of posterior reversible encephalopathy syndrome (PRES)? Acta Radiol. 2013;54(10):1182–90.

    Article  PubMed  Google Scholar 

  51. Liman TG, Bohner G, Endres M, Siebert E. Discharge status and in-hospital mortality in posterior reversible encephalopathy syndrome. Acta Neurol Scand. 2014;130(1):34–9.

    Article  CAS  PubMed  Google Scholar 

  52. Kastrup O, Gerwig M, Frings M, Diener HC. Posterior reversible encephalopathy syndrome (PRES): electroencephalographic findings and seizure patterns. J Neurol. 2012;259(7):1383–9.

    Article  PubMed  Google Scholar 

  53. Kaplan PW, Sutter R. Affair with triphasic waves-their striking presence, mysterious significance, and cryptic origins: what are they? J Clin Neurophysiol. 2015;32(5):401–5.

    Article  PubMed  Google Scholar 

  54. Kamiya-Matsuoka C, Tummala S. Electrographic patterns in patients with posterior reversible encephalopathy syndrome and seizures. J Neurol Sci. 2017;375:294–8.

    Article  PubMed  Google Scholar 

  55. Sha Z, Moran BP, McKinney AM 4th, Henry TR. Seizure outcomes of posterior reversible encephalopathy syndrome and correlations with electroencephalographic changes. Epilepsy Behav. 2015;48:70–4.

    Article  PubMed  Google Scholar 

  56. Murray K, Amin U, Maciver S, Benbadis SR. EEG findings in posterior reversible encephalopathy syndrome. Clin EEG Neurosci. 2019;50(5):366–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank the personnel of the Multidisciplinary Critical Care Unit at the University of Istanbul for support.

Funding

This study was funded by the Scientific Research Projects Coordination Unit of Istanbul University (Grant No. 35165).

Author information

Authors and Affiliations

Authors

Contributions

GO, SS, ET, NB, and FE contributed to conception and design of the study. GO, FE, ET, and PEÖ contributed to acquisition, analysis, and interpretation of data from patients with sepsis. NB contributed to acquisition, analysis, and interpretation of electroencephalographic analysis of patients with sepsis. SS and MB contributed to acquisition, analysis, and interpretation of brain magnetic resonance imaging. MGG performed the statistical analysis. GO, SS, ET, NB, and FE were involved in drafting the manuscript or revising it critically for important intellectual content. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Günseli Orhun.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interests.

Ethical approval/informed consent

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the institutional review board (approval number: 2013/98), and informed consent was obtained from all individual participants, or their relatives, included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 14 kb)

Supplementary file2 (DOCX 14 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Orhun, G., Sencer, S., Tüzün, E. et al. Posterior Reversible Encephalopathy in Sepsis-Associated Encephalopathy: Experience from a Single Center. Neurocrit Care 36, 372–386 (2022). https://doi.org/10.1007/s12028-021-01433-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-021-01433-8

Keywords

Navigation